Recent News

• 04.22.2025 - USANA Health Sciences Reports First Quarter 2025 Results and Reiterates Full-Year Outlook
• 04.14.2025 - Clinical Study Shows USANA Celavive's Resurfacing Serum to Improve Appearance of Skin in Just Two Weeks
• 04.08.2025 - USANA Schedules First Quarter 2025 Earnings Release and Conference Call
• 04.01.2025 - USANA Exec. Chairman Kevin Guest Celebrates Guitar Month, Stress Awareness Month for Harmony

Recent Filings

• 04.22.2025 - EX-99.1 EX-99.1
• 04.22.2025 - 8-K Current report
• 04.16.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.09.2025 - ARS Annual Report to Security Holders
• 04.09.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.04.2025 - DEF 14A Other definitive proxy statements
• 03.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.12.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]